GB761618A — Steroid hormone compositions
Assigned to Merck and Co Inc · Expires 1956-11-14 · 70y expired
What this patent protects
Steroid hormones are solubilized by a pyridine derivative of formula <FORM:0761618/VI/1> where R is an alkoxy, amino or substituted amino radical. Specified derivatives include methyl nicotinate, ethyl nicotinate, methyl isonicotinate, nicotinamide, N, N-diethyl nicotinamid…
USPTO Abstract
Steroid hormones are solubilized by a pyridine derivative of formula <FORM:0761618/VI/1> where R is an alkoxy, amino or substituted amino radical. Specified derivatives include methyl nicotinate, ethyl nicotinate, methyl isonicotinate, nicotinamide, N, N-diethyl nicotinamide, isonicotnic acid hydrazide and pyrizinamide. Adrenal hormones (cortisone, hydrocortisone, corticosterone, desoxycorticosterone and dehydrocorticosterone), estrogenic hormones (a -estradiol), corpus luteum hormone (progesterone) and androgenic hormones (testosterone), alone or mixed, may be solubilized. The composition gives a solution on addition of water or a medicinally acceptable oil. Benzyl alcohol may also be present. The solutions formed may be used for oral, topical, intramuscular, intravenous, opthalmic, nasal or irrigational administration. An example describes the preparation of an aqueous solution of hydrocortisone alcohol and nicotinamide.
Drugs covered by this patent
- Androgel (TESTOSTERONE) · Besins Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.